Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders

Abstract Background Neuromyelitis Optica Spectrum Disorders (NMOSD) comprise a group of autoimmune-mediated, inflammatory, demyelinating central nervous system diseases caused by aquaporin-4 (AQP4) IgG autoantibodies. Efgartigimod is a human IgG Fc fragment that reduces antibody titers by targeting...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wenjing Yang, Pei Chen, Jiaxuan Guo, Huiyu Feng, Xin Huang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-12-01
Serie:	Orphanet Journal of Rare Diseases
Soggetti:	Neuromyelitis optica spectrum disorders Efgartigimod Intravenous methylprednisolone Treatment of acute phase
Accesso online:	https://doi.org/10.1186/s13023-024-03501-6
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!